FHAM
PCRX icon

Folger Hill Asset Management’s Pacira BioSciences PCRX Stock Holding History

Folger Hill Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-250,000
Closed -$8.07M – 353
2016
Q4 		$8.07M Hold
250,000
– – 0.73% 46
2016
Q3 		$8.55M Buy
+250,000
New +$9.79M 0.51% 59

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Folger Hill Asset Management's PCRX Position: Q4 2016 in Review

Folger Hill Asset Management sold out of Pacira BioSciences (PCRX) in Q4 2016, closing a stake of 48,639 shares — an estimated $1.62M sold.

Folger Hill Asset Management first reported a position in PCRX in Q4 2015 and held it in 4 quarters. The position peaked at $19.9M in Q4 2015. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.

  • Folger Hill Asset Management reported no remaining Pacira BioSciences position as of Q4 2016 after selling out during the quarter.
  • Folger Hill Asset Management sold 48,639 Pacira BioSciences shares in Q4 2016, an estimated $1.62M.
  • Folger Hill Asset Management first reported a position in Pacira BioSciences in Q4 2015 and held it in 4 quarters.
  • Folger Hill Asset Management's Pacira BioSciences position peaked at $19.9M in Q4 2015.
  • 182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.

Based on Folger Hill Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.